| Literature DB >> 27588186 |
Maria Helena Ornellas1, Monique De França Silva2, Cristiana Solza3, Stella Beatriz Sampaio De Lucena Gonçalves3, Liliane Silva De Almeida1, Jackline De Paula Ayres-Silva4, Taís Leite Seixas5, Elenice Ferreira Bastos6, Thomas Liehr7, Gilda Alves8.
Abstract
Myelodysplastic syndrome (MDS) cases comprise a heterogeneous group of hematological disorders that are characterized by impaired hematopoiesis, with cytopenias of different grades and risk of developing acute myeloid leukemia. MDS may rarely be associated with thrombocytosis. In such cases, myelodysplasia and myeloproliferative disorders may overlap, making correct diagnosis difficult. We herein describe a case of MDS with thrombocytosis, Janus kinase 2 gene mutation-positive and Perls' staining-negative, which was initially classified as essential thrombocythemia (ET). This case highlights that MDS may be misdiagnosed as ET and inappropriate treatment may be initiated. Therefore, it is crucial to carefully combine all available data on morphology and immunophenotyping, and to perform the necessary molecular, cytogenetic and molecular cytogenetic analyses, in order to correctly diagnose this disease.Entities:
Keywords: Janus kinase 2 gene; aging; complex karyotype; essential thrombocythemia; myelodysplastic syndrome
Year: 2016 PMID: 27588186 PMCID: PMC4997974 DOI: 10.3892/mco.2016.947
Source DB: PubMed Journal: Mol Clin Oncol ISSN: 2049-9450